UGT2A2

UDP glucuronosyltransferase family 2 member A2, the group of UDP glucuronosyltransferases

Basic information

Region (hg38): 4:69588417-69639642

Links

ENSG00000271271NCBI:574537OMIM:619809HGNC:28183Uniprot:P0DTE5AlphaFoldGenCCjaxSfariGnomADPubmedClinVar

Phenotypes

GenCC

Source: genCC

No genCC data.

ClinVar

This is a list of variants' phenotypes submitted to ClinVar and linked to the UGT2A2 gene.

Variants pathogenicity by type

Statistics on ClinVar variants can assist in determining whether a specific variant type in the UGT2A2 gene is commonly pathogenic or not.

In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.

Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.

Variant type Pathogenic Likely pathogenic VUS Likely benign Benign Sum
synonymous
2
clinvar
1
clinvar
3
missense
15
clinvar
1
clinvar
1
clinvar
17
nonsense
1
clinvar
1
start loss
0
frameshift
0
inframe indel
0
splice donor/acceptor (+/-2bp)
0
splice region
0
non coding
1
clinvar
1
Total 0 0 15 5 2

Variants in UGT2A2

This is a list of pathogenic ClinVar variants found in the UGT2A2 region.

You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.

Position Type Phenotype Significance ClinVar
4-69589493-G-T not specified Uncertain significance (Sep 14, 2021)2374899
4-69589587-G-A Likely benign (May 24, 2018)789578
4-69594602-C-T Benign (Aug 17, 2018)780463
4-69594611-T-A Benign (Jul 26, 2018)788781
4-69595205-G-A Likely benign (May 29, 2018)738812
4-69595226-C-A Likely benign (May 11, 2018)717876
4-69596275-G-A not specified Uncertain significance (Sep 26, 2023)3186146
4-69599312-A-C Likely benign (May 29, 2018)738813
4-69599313-C-T not specified Uncertain significance (Dec 01, 2022)2343860
4-69635828-C-CAAAAAAAAAA Likely benign (Jan 01, 2023)2654790
4-69638932-C-T not specified Uncertain significance (Jun 16, 2024)3330851
4-69638935-A-C not specified Uncertain significance (Oct 03, 2023)3186149
4-69639004-T-C not specified Uncertain significance (Apr 26, 2023)2512349
4-69639142-G-A not specified Uncertain significance (Oct 13, 2023)3186148
4-69639190-C-G not specified Uncertain significance (Jun 24, 2022)2406614
4-69639201-C-T not specified Uncertain significance (Dec 05, 2022)2209279
4-69639288-T-C not specified Uncertain significance (Dec 08, 2021)2227882
4-69639373-T-C not specified Uncertain significance (Apr 09, 2024)3330852
4-69639436-A-G not specified Uncertain significance (Feb 23, 2023)2468684
4-69639486-A-C not specified Uncertain significance (Nov 08, 2022)3186147
4-69639501-A-G not specified Uncertain significance (Oct 04, 2022)2316791
4-69639508-T-C not specified Uncertain significance (Aug 28, 2023)2621636
4-69639615-A-C not specified Uncertain significance (Nov 18, 2022)2327526
4-69639631-T-C not specified Uncertain significance (Aug 10, 2023)2617714

GnomAD

Source: gnomAD

GeneTypeBio TypeTranscript Coding Exons Length
UGT2A2protein_codingprotein_codingENST00000457664 651226
pLI Probability
LOF Intolerant
pRec Probability
LOF Recessive
Individuals with
no LOFs
Individuals with
Homozygous LOFs
Individuals with
Heterozygous LOFs
Defined p
4.75e-140.026312542703191257460.00127
Z-Score Observed Expected Observed/Expected Mutation Rate Total Possible in Transcript
Missense-1.703582781.290.00001303513
Missense in Polyphen12095.0021.26311263
Synonymous-1.6911896.81.220.000004821014
Loss of Function0.1692121.90.9610.00000118269

LoF frequencies by population

EthnicitySum of pLOFs p
African & African-American0.007720.00756
Ashkenazi Jewish0.001690.00169
East Asian0.002270.00223
Finnish0.00009250.0000924
European (Non-Finnish)0.0009040.000897
Middle Eastern0.002270.00223
South Asian0.0006920.000686
Other0.0006600.000652

dbNSFP

Source: dbNSFP

Function
FUNCTION: UDP-glucuronosyltransferases catalyze phase II biotransformation reactions in which lipophilic substrates are conjugated with glucuronic acid to increase water solubility and enhance excretion. They are of major importance in the conjugation and subsequent elimination of potentially toxic xenobiotics and endogenous compounds. Active on odorants and seems to be involved in olfaction; it could help clear lipophilic odorant molecules from the sensory epithelium. {ECO:0000269|PubMed:19858781}.;
Pathway
Retinol metabolism - Homo sapiens (human);Steroid hormone biosynthesis - Homo sapiens (human);Metabolism of xenobiotics by cytochrome P450 - Homo sapiens (human);Drug metabolism - other enzymes - Homo sapiens (human);Drug metabolism - cytochrome P450 - Homo sapiens (human);Porphyrin and chlorophyll metabolism - Homo sapiens (human);Chemical carcinogenesis - Homo sapiens (human);Ascorbate and aldarate metabolism - Homo sapiens (human);Pentose and glucuronate interconversions - Homo sapiens (human);Glucuronidation;Metapathway biotransformation Phase I and II;Glucuronidation;Phase II - Conjugation of compounds;Biological oxidations;Metabolism (Consensus)

Intolerance Scores

loftool
rvis_EVS
1.69
rvis_percentile_EVS
96.41

Haploinsufficiency Scores

pHI
hipred
N
hipred_score
0.112
ghis

Essentials

essential_gene_CRISPR
N
essential_gene_CRISPR2
essential_gene_gene_trap
gene_indispensability_pred
gene_indispensability_score

Gene Damage Prediction

AllRecessiveDominant
MendelianMediumMediumMedium
Primary ImmunodeficiencyMediumMediumMedium
CancerMediumMediumMedium

Mouse Genome Informatics

Gene name
Ugt2a2
Phenotype